Wyeth shareholders approve merger with Pfizer
This article was originally published in Scrip
Executive Summary
Wyeth shareholders have voted strongly to approve the company's $68 billion merger with Pfizer, paving the way for the deal's closing later this year. More than 98% of the firm's shareholders voted to permit the buyout, according to a preliminary vote count.